In 2013, a physician-entrepreneur at Stanford was inspired to action, after witnessing patients with life-limiting illness receive aggressive care in the ICU against their wishes. The reason? Advance care planning documents were not electronically available at the point of care to guide clinicians. With no available solution, the physician joined forces with another physician and two engineers to develop a SaaS based technology. This session will discuss how the team leveraged the Stanford Biodesign Innovation process to develop a Saas based solution, the challenges that come with a startup, including the commercialization of a solution, and navigating and securing seed, Series A, and a $10.3M Series B funding round. This session will also feature an investor who participated in the most recent funding round, why they invested in this particular company, and what they look for when investing in startups.